Ritva Hurskainen Selected Research

Levonorgestrel (Plan B)

11/2016	Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube.
1/2016	Levonorgestrel-releasing intrauterine system and the risk of breast cancer: A nationwide cohort study.
8/2014	Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.
12/2013	Quality of life and costs of levonorgestrel-releasing intrauterine system or hysterectomy in the treatment of menorrhagia: a 10-year randomized controlled trial.
3/2012	The effect of hysterectomy or levonorgestrel-releasing intrauterine system on premenstrual symptoms in women treated for menorrhagia: secondary analysis of a randomized controlled trial.
3/2011	Cost-effectiveness and quality of life associated with heavy menstrual bleeding among women using the levonorgestrel-releasing intrauterine system.
1/2009	The effect of hysterectomy or levonorgestrel-releasing intrauterine system on lower abdominal pain and back pain among women treated for menorrhagia: a five-year randomized controlled trial.
7/2007	Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK.
1/2007	Depressive symptoms as predictors of discontinuation of treatment of menorrhagia by levonorgestrel-releasing intrauterine system.
10/2006	Managing drug-resistant essential menorrhagia without hysterectomy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ritva Hurskainen Research Topics

Disease

15	Menorrhagia 11/2016 - 01/2003
4	Neoplasms (Cancer) 01/2017 - 08/2014
3	Breast Neoplasms (Breast Cancer) 01/2017 - 08/2014
1	Leiomyoma (Uterine Fibroids) 01/2017
1	Endometrial Neoplasms (Endometrial Cancer) 01/2017
1	Lung Neoplasms (Lung Cancer) 08/2014
1	Adenocarcinoma 08/2014
1	Anemia 07/2014
1	Postoperative Pain 01/2014
1	Premenstrual Syndrome (Premenstrual Tension) 03/2012
1	Thromboembolism 01/2012
1	Thrombosis (Thrombus) 01/2012
1	Pain (Aches) 06/2010
1	Back Pain (Backache) 01/2009
1	Abdominal Pain (Pain, Abdominal) 01/2009
1	Pelvic Pain 04/2003
1	Hemorrhage 04/2003
1	Dysmenorrhea (Menstrual Pain) 02/2003

Drug/Important Bio-Agent (IBA)

14	Levonorgestrel (Plan B)FDA LinkGeneric 11/2016 - 01/2003
2	Hormones (Hormone)IBA 11/2016 - 01/2016
1	SteroidsIBA 01/2016
1	IronIBA 07/2014
1	Tranexamic Acid (AMCA)FDA Link 01/2012
1	Misoprostol (Cytotec)FDA LinkGeneric 06/2010
1	2,2'-thiobis(ethyl acetoacetate)IBA 07/2007
1	Pharmaceutical PreparationsIBA 10/2006

Therapy/Procedure

11	Hysterectomy 01/2017 - 02/2003
2	Therapeutics 11/2016 - 01/2016
1	Endometrial Ablation Techniques 01/2017
1	Contraception (Birth Control) 11/2016
1	Aftercare (After-Treatment) 07/2014
1	Surgical Instruments (Clip) 01/2014
1	Contraindications 01/2012
1	Ambulatory Care (Outpatient Care) 02/2003